Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China [CNBC]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: CNBC
phase out the use of petroleum-based synthetic dyes in the nation's food supply during a press conference at the Department of Health and Human Services in Washington, D.C., U.S., April 22, 2025. REUTERS/Elizabeth Frantz Elizabeth Frantz | Reuters A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. This week, I had a chance to sit down with Food and Drug Administration Commissioner Dr. Marty Makary during a trip to Washington, D.C. Our conversation came in the midst of a contentious stretch for the FDA, defined by a leadership transition, massive staff and budget cuts and sweeping changes to vaccine policy and the agency's drug approval approach. Most recently, its back-and-forth on Moderna's flu shot has fueled industry concern about regulatory consistency. Here's what Makary had to say on some of the topics top of mind for the pharmaceutica
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk's Wegovy® Pill Achieves Strong First-Month Uptake, Signaling Expanding Demand for Oral GLP-1s in Obesity [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk A/S: Notice for the Annual General Meeting of Novo Nordisk A/S [Yahoo! Finance]Yahoo! Finance
- What Is HIMS Worth Without GLP-1? Earnings Preview [Seeking Alpha]Seeking Alpha
- The GLP-1 treatment you want is in a convenient daily pill [USA TODAY]USA TODAY
- Hims & Hers Health to acquire Australia's Eucalyptus for up to $1.15 billion [CNBC]CNBC
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 2/20/26 - Form 6-K
- 2/17/26 - Form 6-K
- 2/11/26 - Form 6-K
- NVO's page on the SEC website